Epilex Oral Solution contains Sodium Valproate 200mg/5ml, an anticonvulsant agent indicated for the management of epilepsy and seizure disorders. It is primarily used to control various types of seizures, including generalized tonic-clonic, absence, myoclonic, and complex partial seizures. Sodium Valproate acts by increasing the availability of gamma-aminobutyric acid (GABA) in the brain, thereby stabilizing neuronal activity and preventing abnormal electrical discharges. Epilex Oral Solution is suitable for patients who require flexible dosing, including pediatric and adult populations, and is administered orally. The solution formulation allows for precise dose adjustments, facilitating individualized therapy. It is essential to adhere to prescribed dosages to minimize the risk of side effects, which may include gastrointestinal disturbances, tremors, weight gain, and, rarely, hepatotoxicity or pancreatitis. Regular monitoring of liver function tests and blood counts is recommended during prolonged therapy. Epilex Oral Solution should be used with caution in patients with pre-existing liver disease or mitochondrial disorders. It is contraindicated during pregnancy unless clearly necessary due to potential teratogenic effects. Consultation with a healthcare professional is advised before initiating or discontinuing therapy to ensure optimal seizure control and patient safety.